We use cookies so that we can improve the experience for visitors to our websites. This includes cookies that are necessary for the operation of our websites, as well as other cookies used for analytics purposes. We will not use analytical cookies unless you enable them.
For more information about our use of cookies, please refer to our cookie policy.
These cookies allow us to understand how our websites are used, and to improve our websites over time.
Enable analytics cookies:
Save and close
Indivior is working to change patients' lives by developing medicines to treat substance use disorders and serious mental illnesses.
Our 2022 Annual Report is available to download
March 2 2023
Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc.
March 27 2023
Annual Report and Accounts 2022
Accelerate your career by making a difference
Driving development in addressing addiction and behavioural health issues
The latest information on Indivior
